Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR407899 in mild to moderate erectile dysfunction
NCT00914277Phase 2Completed
- Sponsor
- Sanofi
- Start
- May 2009
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SAR407899 in erectile dysfunction (ED), sponsored by Sanofi. Started May 2009; status: completed.
02
Drugs
SAR407899
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00914277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00914277.